Abstract
Oral RNA has been used in the past as a nutritional supplement as well as a therapeutic agent for several disorders. It is difficult to validate any of the therapeutic claims in the absence of scientific studies and in view of the instability of orally administered RNA. Absorption from the gastrointestinal tract remains questionable. Most of the current efforts in relation to oral RNA are devoted to oral administration of siRNA for therapeutic purposes. A hypothesis is presented of the usefulness of RNA as a nutraceutical. After review of the available literature, role of mRNA in the body, and various routes of administration, suggestions are made for possible methods to improve delivery of RNA and to study its pharmacokinetics. There is commercial potential for such a product if absorption by oral route can be verified as it is easy to administer and can be produced at lower cost than intravenous preparations.
Keywords: Drug delivery, immunomodulators, mRNA, DNA, nucleic acids, nucleotides, nutraceuticals, oral RNA, RNA therapeutics, yeast RNA
Current Drug Delivery
Title: Stability and Delivery of RNA Via the Gastrointestinal Tract
Volume: 5 Issue: 1
Author(s): K. K. Jain
Affiliation:
Keywords: Drug delivery, immunomodulators, mRNA, DNA, nucleic acids, nucleotides, nutraceuticals, oral RNA, RNA therapeutics, yeast RNA
Abstract: Oral RNA has been used in the past as a nutritional supplement as well as a therapeutic agent for several disorders. It is difficult to validate any of the therapeutic claims in the absence of scientific studies and in view of the instability of orally administered RNA. Absorption from the gastrointestinal tract remains questionable. Most of the current efforts in relation to oral RNA are devoted to oral administration of siRNA for therapeutic purposes. A hypothesis is presented of the usefulness of RNA as a nutraceutical. After review of the available literature, role of mRNA in the body, and various routes of administration, suggestions are made for possible methods to improve delivery of RNA and to study its pharmacokinetics. There is commercial potential for such a product if absorption by oral route can be verified as it is easy to administer and can be produced at lower cost than intravenous preparations.
Export Options
About this article
Cite this article as:
Jain K. K., Stability and Delivery of RNA Via the Gastrointestinal Tract, Current Drug Delivery 2008; 5 (1) . https://dx.doi.org/10.2174/156720108783331023
DOI https://dx.doi.org/10.2174/156720108783331023 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases
Current Topics in Medicinal Chemistry Effect of a New Class of Compounds of the Group of Substituted 5R1, 6H2-1,3,4-thiadiazine-2-amines on the Inflammatory and Cytokine Response in Experimental Myocardial Infarction
Current Vascular Pharmacology Adverse Effects of Statins - Mechanisms and Consequences
Current Drug Safety The Pathogenic Subpopulation of Th17 Cells in Obesity
Current Pharmaceutical Design New Perspectives of Infections in Cardiovascular Disease
Current Cardiology Reviews Acute Antithrombotic Treatment of Ischemic Stroke
Current Vascular Pharmacology Editorial (Thematic Issue: The Crosstalk between Non-Pharmaceutical and Pharmaceutical Approaches to Prevention and Treatment of Chronic Diseases: Current Concepts and Perspectives)
Current Pharmaceutical Design Cachexia and Herbal Medicine: Perspective
Current Pharmaceutical Design Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?
Current Vascular Pharmacology Cancer Prevention by Dietary Bioactive Components that Target the Immune Response
Current Cancer Drug Targets Hypolipidaemic Drug Treatment: Yesterday is Not Gone Yet, Today is Challenging and Tomorrow is Coming Soon; let us Combine them all
Current Pharmaceutical Design Drug Targets for Obesity and Depression: From Serotonin to Leptin
Current Drug Targets TRPV1 and TRPA1 in Pulmonary Vagal Afferents and their Relations to Airway Sensitivity
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Therapeutic Potential of Essential Oil-based Microemulsions: Reviewing State-of-the-art
Current Drug Delivery Intestinal Permeability in Non-alcoholic Fatty LIVER Disease: The Gut-liver Axis
Reviews on Recent Clinical Trials Molecular Genetics of Quantitative Fibrinogen Disorders
Cardiovascular & Hematological Agents in Medicinal Chemistry Treatment of Chronic Peripheral Arterial Disease
Current Vascular Pharmacology Apoptosis and Efferocytosis in Mouse Models of Atherosclerosis
Current Drug Targets Editorial (Thematic Issue: Cell Immunity in Cardiovascular and Cerebrovascular Diseases)
Current Immunology Reviews (Discontinued) Inflammatory Cytokines and Atherosclerosis Possible Application for the Gene Therapy
Vascular Disease Prevention (Discontinued)